TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25327942

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC, 2-3 min after birth)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Early cord clamping (ECC, <30 s)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 104
Study: 23148286

Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir (atazanavir/r)
Number of subjects: 646

Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 646
Study: 20816039

Group type: EXPERIMENTAL
Intervention: Adjunctive aripiprazole (2‐20 mg/d)
Number of subjects: 737

Group type: COMPARATOR
Intervention: Adjunctive placebo
Number of subjects: 737
Study: 18427147

Group type: EXPERIMENTAL
Intervention: Risedronate 35 mg once weekly
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 16532712

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blockers (ARB)
Number of subjects: 2438
Study: 12692113

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 330

Group type: COMPARATOR
Intervention: Immediate colposcopy
Number of subjects: 330

Group type: COMPARATOR
Intervention: Repeat cytology of HSIL
Number of subjects: 330
Study: 11035984

Group type: EXPERIMENTAL
Intervention: Progesterone and progestins; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Estrogen; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 8933313

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (2 g daily with 1 g probenecid)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Cefazolin (2 g daily with 1 g probenecid)
Number of subjects: 194
Study: 1416576

Group type: EXPERIMENTAL
Intervention: r‐HuEPO (100 to 200 U/kg body weight), intravenously or subcutaneously, three times per week for up to 12 weeks
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study: 3993879

Group type: EXPERIMENTAL
Intervention: Sedation with etomidate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sedation with thiopental
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: EEG monitoring
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patients with septicaemia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Spectral analysis and computed parameters
Number of subjects: 40
Study: 31208393

Group type: EXPERIMENTAL
Intervention: 0.05% cyclosporine (CN)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: 3% diquafosol (DQ)
Number of subjects: 153
Study: 29134744

Group type: EXPERIMENTAL
Intervention: Oral sodium propionate (6845 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sodium chloride (4164 mg)
Number of subjects: 18
Study: 27590594

Group type: EXPERIMENTAL
Intervention: Altruism expressed by acceptors and decliners
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Overriding personal needs in decliners
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pure altruism in acceptors
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Hypothetical altruism amongst acceptors
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Weak altruism amongst acceptors
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Conditional altruism amongst acceptors
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sense of duty to participate
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Understanding of trial rationale
Number of subjects: 39
Study: 23334387

Group type: EXPERIMENTAL
Intervention: Lifestyle maintenance program (n = 112)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard care (n = 98)
Number of subjects: 210
Study: 22767424

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral system of psychotherapy (CBASP) + ADM
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Brief supportive psychotherapy (BSP) + ADM
Number of subjects: 785

Group type: COMPARATOR
Intervention: ADM only
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Any treatment preference
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Medication only preference
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Combined treatment preference
Number of subjects: 785
Study: 20039429

Group type: EXPERIMENTAL
Intervention: mycophenolate mofetil (target dosage 3 gm/day)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: intravenous cyclophosphamide (0.5‐1.0 gm/m(2)/month)
Number of subjects: 370
Study: 17321816

Group type: EXPERIMENTAL
Intervention: modified constraint‐induced movement therapy (mCIMT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: traditional rehabilitation
Number of subjects: 26
Study: 15333078

Group type: EXPERIMENTAL
Intervention: Oral d,l‐sotalol (196 +/- 42 mg/day for 7 days)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Oral d,l‐sotalol (216 +/- 51 mg/day)
Number of subjects: 19
Study: 11605744

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) in adherent PBMC group (n = 20)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) in total PBMC group (n = 9)
Number of subjects: 30

Group type: COMPARATOR
Intervention: In vitro culture with 10(‐8) M 17beta‐estradiol or tibolone
Number of subjects: 30
Study: 11819342

Group type: EXPERIMENTAL
Intervention: Yinchenhao Chengqi decoction combined with endoscopic sphincterotomy (EST)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (EST)
Number of subjects: 21
Study: 8085482

Group type: EXPERIMENTAL
Intervention: Structured Learning Therapy (SLT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 2665639

Group type: EXPERIMENTAL
Intervention: Zinc gluconate (23 mg of elemental zinc lozenges taken every 2 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (taste-matched sucrose octaacetate lozenges)
Number of subjects: 0
Study: 595718

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tolbutamide
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Carbutamide
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Buformin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 100
Study: 31951291

Group type: EXPERIMENTAL
Intervention: Evidence-based parenting programs focusing on behavioral and physical health
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation of parenting programs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Financial and organizational outcomes
Number of subjects: 0
Study: 30817465

Group type: EXPERIMENTAL
Intervention: Isometric exercise training (IET)
Number of subjects: 24
Study: 26719349

Group type: EXPERIMENTAL
Intervention: Carer Support Needs Assessment Tool (CSNAT) intervention
Number of subjects: 681

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 681
Study: 25923550

Group type: EXPERIMENTAL
Intervention: Rociletinib (500 mg to 1000 mg twice daily)
Number of subjects: 130
Study: 23889096

Group type: EXPERIMENTAL
Intervention: Liquid formulation of benazepril (0.45 mg/kg daily for 4 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tablet formulation of benazepril (0.45 mg/kg daily for 4 days)
Number of subjects: 12
Study: 21742089

Group type: EXPERIMENTAL
Intervention: Intraaortic balloon counterpulsation (IABC) initiated before primary PCI and continued for at least 12 hours
Number of subjects: 300

Group type: COMPARATOR
Intervention: Routine PCI with standard-of-care medical therapy
Number of subjects: 300
Study: 19738991

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 63

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 63
Study: 15699810

Group type: COMPARATOR
Intervention: Iliac crest bone graft harvest
Number of subjects: 208

Group type: COMPARATOR
Intervention: Graft site appearance assessment
Number of subjects: 208
Study: 12074359

Group type: EXPERIMENTAL
Intervention: Omapatrilat (40 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Lisinopril (20 mg daily)
Number of subjects: 22
Study: 10431554

Group type: EXPERIMENTAL
Intervention: Familial combined hyperlipidemia (FCH) patients
Number of subjects: 430

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Patients with hypertension
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Patients with secondary hypertension due to renal artery stenosis (RAS)
Number of subjects: 430
Study: 8924548

Group type: EXPERIMENTAL
Intervention: Theophylline 300 mg twice a day (E1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Salbutamol 4 mg tid (E2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of Theophylline 200 mg and Salbutamol 4 mg (E3)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of Theophylline 100 mg and Salbutamol 2 mg (E4)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo calcium lactate 300 mg tid (E5)
Number of subjects: 30
Study: 1978872

Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 10
Study: 6105025

Group type: EXPERIMENTAL
Intervention: Metoprolol (n=10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Propranolol (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Euthyroid subjects (n=12)
Number of subjects: 20
Study: 30266438

Group type: COMPARATOR
Intervention: Fear acquisition and fear generalization phase (day 1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Extinction learning phase (day 2)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Extinction recall phase (day 3)
Number of subjects: 46
Study: 27932240

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream once daily (superficial basal cell carcinoma, 6 weeks; nodular basal cell carcinoma, 12 weeks)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Excisional surgery (4-mm margin)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream once daily
Number of subjects: 501
Study: 25216962

Group type: EXPERIMENTAL
Intervention: EMLA patches on all abdominal incisions
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo patches on all abdominal incisions
Number of subjects: 121
Study: 24063362

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 290

Group type: COMPARATOR
Intervention: Liberal transfusion strategy
Number of subjects: 290
Study: 21880031

Group type: EXPERIMENTAL
Intervention: air-Q(®)
Number of subjects: 100

Group type: COMPARATOR
Intervention: ProSeal
Number of subjects: 100
Study: 18474393

Group type: EXPERIMENTAL
Intervention: Warfarin (INR 2.8-4.2)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg/d and Warfarin (INR 2.0-2.5)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Aspirin 160 mg/d
Number of subjects: 186
Study: 17538059

Group type: EXPERIMENTAL
Intervention: Intervention targeting multiple risk-related behaviors
Number of subjects: 2928

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 2928
Study: 15148146

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation of the subthalamic nucleus (STN)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Long-term STN deep brain stimulation
Number of subjects: 23
Study: 11795688

Group type: EXPERIMENTAL
Intervention: cream with phytoestrogens
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo (cold cream)
Number of subjects: 30
Study: 9709785

Group type: EXPERIMENTAL
Intervention: Oral iron supplementation (285.6 mg of elemental iron/day)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Oral iron plus intravenous iron supplementation (285.6 mg of elemental iron/day orally plus 102.5 mg of elemental iron/week intravenously)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo (no iron supplementation)
Number of subjects: 108
Study: 8071390

Group type: EXPERIMENTAL
Intervention: 600‐mg methocel tablet (sustained-release)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 300‐mg CAP/carbovax-coated tablet (immediate-release)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 600‐mg sustained-release tablet
Number of subjects: 20

Group type: COMPARATOR
Intervention: 300‐mg tablet b.i.d.
Number of subjects: 20
Study: 2487031

Group type: EXPERIMENTAL
Intervention: Marital interaction patterns (disagreement and anger exchanges)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Defensiveness (including whining), stubbornness, and withdrawal from interaction
Number of subjects: 0
Study: 29766748

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) enriched 5% oil formulation with 0.25% δ‐9‐tetrahydrocannabinol (THC) 20:1
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) enriched 5% oil formulation with 0.83% THC 6:1
Number of subjects: 25
Study: 28547573

Group type: EXPERIMENTAL
Intervention: TLIF procedure using autologous iliac crest bone grafts (ICBGs) alone (Group A)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: TLIF procedure using local bone from decompression site mixed with hydroxyapatite (Group B)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 48
Study: 26617135

Group type: EXPERIMENTAL
Intervention: Enteral Nutritional Support (EN)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Parenteral Nutritional Support (PN)
Number of subjects: 120
Study: 23354440

Group type: EXPERIMENTAL
Intervention: Group A (received < 26 Gy to the left and right parotids)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Group B (received < 26 Gy to either parotid)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 126

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 126
Study: 21905997

Group type: EXPERIMENTAL
Intervention: High frequency rTMS (20 Hz) over the left DLPFC (n = 10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham stimulation (n = 9)
Number of subjects: 19
Study: 18787350

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel at a dose of 100 mg/m(2) plus radiotherapy (group I)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Radiotherapy only (group II)
Number of subjects: 61
Study: 16969042

Group type: EXPERIMENTAL
Intervention: Gemcitabine; specific dosage and duration not mentioned
Number of subjects: 0
Study: 12560435

Group type: EXPERIMENTAL
Intervention: CMF plus ADM (doxorubicin)
Number of subjects: 506

Group type: COMPARATOR
Intervention: CMF alone
Number of subjects: 506
Study: 10218338

Group type: EXPERIMENTAL
Intervention: Surfactant therapy using the INSURE approach (Intubation‐SURfactant‐Extubation)
Number of subjects: 12
Study: 8622034

Group type: EXPERIMENTAL
Intervention: Adjuvant brachytherapy (BRT)
Number of subjects: 164

Group type: COMPARATOR
Intervention: No further therapy (no BRT)
Number of subjects: 164
Study: 2006722

Group type: EXPERIMENTAL
Intervention: Propofol 10 mg kg‐1 h‐1
Number of subjects: 28

Group type: COMPARATOR
Intervention: 1 MAC enflurane
Number of subjects: 28
Study: 6216344

Group type: EXPERIMENTAL
Intervention: Piperacillin (181 mg/kg intravenous daily for 6 days)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Carbenicillin (270 mg/kg intravenous daily for 6 days)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 56

Group type: COMPARATOR
Intervention: Carbenicillin
Number of subjects: 56
Study: 31204406

Group type: EXPERIMENTAL
Intervention: Short sampling time (15 minutes)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard sampling time (30 minutes)
Number of subjects: 151
Study: 28532895

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Prevailing health education
Number of subjects: 512
Study: 25942421

Group type: EXPERIMENTAL
Intervention: Specialist geriatric medical intervention (geriatrician assessment in acute units and further specialist management)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 433
Study: 23407820

Group type: EXPERIMENTAL
Intervention: Active list management program consisting of a telephonic interview on 21 items to evaluate socioeconomic features, self‐perceived health status, social support, referral physician, accessibility and patients' satisfaction.
Number of subjects: 501

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 501
Study: 20052619

Group type: EXPERIMENTAL
Intervention: Depression care management
Number of subjects: 479
Study: 18406045

Group type: EXPERIMENTAL
Intervention: Initially suspicious DRE
Number of subjects: 2218

Group type: COMPARATOR
Intervention: Initially normal DRE
Number of subjects: 2218
Study: 17575485

Group type: EXPERIMENTAL
Intervention: Granisetron injection
Number of subjects: 42

Group type: COMPARATOR
Intervention: Isotonic saline injection
Number of subjects: 42
Study: 14752215

Group type: EXPERIMENTAL
Intervention: Butterbur root extract (Petadolex), 25 mg, two capsules twice a day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11822760

Group type: EXPERIMENTAL
Intervention: Nolatrexed 725 mg/m2 per day (5-day continuous infusion every three weeks)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Methotrexate 40 mg/m2 weekly (short infusion)
Number of subjects: 139
Study: 10672490

Group type: EXPERIMENTAL
Intervention: Vibration at 50 m/s2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vibration at 30 m/s2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (0 m/s2 vibration)
Number of subjects: 20
Study: 9229824

Group type: EXPERIMENTAL
Intervention: Eiconol (polyunsaturated fatty acids of omega-3 class) for two weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8209058

Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation (3.33 x 10(‐4) M)
Number of subjects: 24
Study: 3533561

Group type: EXPERIMENTAL
Intervention: urapidil
Number of subjects: 40

Group type: COMPARATOR
Intervention: metoprolol
Number of subjects: 40
Study: 30300104

Group type: EXPERIMENTAL
Intervention: Gain-framed quit messages
Number of subjects: 182

Group type: COMPARATOR
Intervention: Loss-framed quit messages
Number of subjects: 182
Study: 27494094

Group type: EXPERIMENTAL
Intervention: Neck-specific training in combination with a cognitive behavioural approach
Number of subjects: 75

Group type: COMPARATOR
Intervention: Prescribed physical activity
Number of subjects: 75
Study: 25282031

Group type: EXPERIMENTAL
Intervention: CoQ10 100 mg 3 times daily
Number of subjects: 420

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 420
Study: 22429566

Group type: EXPERIMENTAL
Intervention: Avonex
Number of subjects: 84

Group type: COMPARATOR
Intervention: CinnoVex
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 19607755

Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Combination of nefazodone and Cognitive Behavioral Analysis System of Psychotherapy
Number of subjects: 171

Group type: COMPARATOR
Intervention: No dyadic discord (MAS score <= 2.36)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 171
Study: 18346608

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 10
Study: 16477764

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (200 mg daily for 15 months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 12189442

Group type: EXPERIMENTAL
Intervention: L-arginine infusion (3 g in 10 ml saline)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 20
Study: 10341457

Group type: EXPERIMENTAL
Intervention: Female physicians
Number of subjects: 510

Group type: COMPARATOR
Intervention: Male physicians
Number of subjects: 510
Study: 8596497

Group type: EXPERIMENTAL
Intervention: Corn oil-enriched diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: Margarine-enriched diet
Number of subjects: 14
Study: 1955626

Group type: EXPERIMENTAL
Intervention: 12 tablets of the supplement a day for three menstrual cycles
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 6 tablets of the supplement a day for three menstrual cycles
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 30345295

Group type: EXPERIMENTAL
Intervention: Treadmill walking training (TW)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Nordic walking training (NW)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Resistance and Nordic walking training (RES+NW)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 95
Study: 29952499

Group type: EXPERIMENTAL
Intervention: Music listening
Number of subjects: 332

Group type: COMPARATOR
Intervention: No music listening (control)
Number of subjects: 332
Study: 24690514

Group type: EXPERIMENTAL
Intervention: Nicotine gum (6 mg)
Number of subjects: 64
Study: 23026843

Group type: EXPERIMENTAL
Intervention: Clopidogrel besylate 75 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel bisulfate 75 mg
Number of subjects: 40
Study: 20565562

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment
Number of subjects: 926

Group type: COMPARATOR
Intervention: Topical corticosteroids
Number of subjects: 926
Study: 17899308

Group type: EXPERIMENTAL
Intervention: Cevimeline hydrochloride 30 mg three times per day for 10 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cevimeline hydrochloride
Number of subjects: 50
Study: 16871247

Group type: EXPERIMENTAL
Intervention: Fosinopril 5 mg titrated to 20 mg daily
Number of subjects: 397

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 397
Study: 14520697

Group type: EXPERIMENTAL
Intervention: Ile/Val or Val/Val genotype in gastric cancer patients
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Val/Val genotype
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Ile/Val genotype
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Ile/Val or Val/Val genotype
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: HER-2 genotype
Number of subjects: 212